Sanofi (NASDAQ:SNY) Shares Bought by Keybank National Association OH

Keybank National Association OH boosted its position in shares of Sanofi (NASDAQ:SNY) by 9.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,105 shares of the company’s stock after buying an additional 913 shares during the period. Keybank National Association OH’s holdings in Sanofi were worth $487,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the stock. Charles Schwab Investment Management Inc. increased its holdings in shares of Sanofi by 8.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 151,945 shares of the company’s stock valued at $7,328,000 after purchasing an additional 12,440 shares during the period. Steward Partners Investment Advisory LLC increased its holdings in shares of Sanofi by 12.6% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 59,973 shares of the company’s stock valued at $2,893,000 after purchasing an additional 6,701 shares during the period. Meridian Wealth Management LLC increased its holdings in shares of Sanofi by 3.3% in the fourth quarter. Meridian Wealth Management LLC now owns 43,782 shares of the company’s stock valued at $2,112,000 after purchasing an additional 1,413 shares during the period. Mission Wealth Management LP increased its holdings in shares of Sanofi by 8.7% in the fourth quarter. Mission Wealth Management LP now owns 7,748 shares of the company’s stock valued at $374,000 after purchasing an additional 621 shares during the period. Finally, Jones Financial Companies Lllp increased its holdings in shares of Sanofi by 55.0% in the fourth quarter. Jones Financial Companies Lllp now owns 15,122 shares of the company’s stock valued at $729,000 after purchasing an additional 5,366 shares during the period. Institutional investors and hedge funds own 14.04% of the company’s stock.

Sanofi Stock Down 0.3 %

Sanofi stock opened at $59.25 on Monday. The stock’s 50 day moving average price is $52.65 and its 200 day moving average price is $52.73. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.46 and a quick ratio of 1.14. The company has a market cap of $150.37 billion, a PE ratio of 23.80, a price-to-earnings-growth ratio of 1.01 and a beta of 0.58. Sanofi has a 1-year low of $45.22 and a 1-year high of $59.72.

Sanofi (NASDAQ:SNY) last posted its earnings results on Thursday, January 30th. The company reported $0.70 EPS for the quarter, hitting analysts’ consensus estimates of $0.70. Sanofi had a return on equity of 25.61% and a net margin of 12.77%. On average, sell-side analysts predict that Sanofi will post 4.36 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on SNY. StockNews.com downgraded Sanofi from a “buy” rating to a “hold” rating in a research note on Thursday, December 12th. Deutsche Bank Aktiengesellschaft upgraded Sanofi from a “sell” rating to a “hold” rating in a research note on Thursday, January 30th. Finally, Sanford C. Bernstein upgraded Sanofi to a “strong-buy” rating in a research note on Thursday, January 30th. Two equities research analysts have rated the stock with a hold rating, one has given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $60.00.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.